JAC Advance Access published online on December 4, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh010
© 2003 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leading article
1 Department of Immunology,
Division of Investigative Science, Faculty of Medicine, Imperial
College of Science, Technology and Medicine, The Chelsea and Westminster
Hospital, 369 Fulham Road, London SW10 9NH, UK;
* Corresponding author. E-mail: j.stebbing{at}imperial.ac.uk.
Heat shock proteins interact with antigen-presenting
cells through their receptor, CD91, eliciting a cascade of events
including maturation, activation and representation of chaperoned
foreign peptides with class I molecules on their surface. In turn,
this facilitates recognition of non-self leading to induction of
a cytotoxic T cell response. The abundance of heat shock proteins
in tumours and their presence in virion coats makes them attractive
propositions for use in antitumour and antiviral strategies.
Keywords: heat shock proteins, HIV, cancer, receptors
All for CD91 and CD91 for all
2 Department of Oncology, Velindre
Hospital, Cardiff, Wales, UK
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Presicce, S. Giannelli, A. Taddeo, M. L. Villa, and S. Della Bella Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91 J. Leukoc. Biol., October 1, 2009; 86(4): 941 - 948. [Abstract] [Full Text] [PDF] |
||||
